{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T06:34:40Z","timestamp":1775802880048,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,24]],"date-time":"2024-03-24T00:00:00Z","timestamp":1711238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,24]],"date-time":"2024-03-24T00:00:00Z","timestamp":1711238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["APQ-00820-19"],"award-info":[{"award-number":["APQ-00820-19"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["APQ-01548-21"],"award-info":[{"award-number":["APQ-01548-21"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["Finance Code 001"],"award-info":[{"award-number":["Finance Code 001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004809","name":"Financiadora de Estudos e Projetos","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009730","name":"Universidade Federal de Ouro Preto","doi-asserted-by":"publisher","award":["3109.014957\/2022-44"],"award-info":[{"award-number":["3109.014957\/2022-44"]}],"id":[{"id":"10.13039\/501100009730","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Gout and hyperuricemia are characterized by high uric acid levels, and their treatment involves medications that have adverse effects. In this study, we evaluated oral liposomal formulations with eremantholide C and goyazensolide as a novel approach to reduce the toxicity associated with these substances while maintaining their anti-hyperuricemic activity. We characterized the formulations and evaluated them based on encapsulation efficiency and stability over 12 months and under simulated physiological environments. We determined the toxicity of the liposomal formulations in Caco-2 cells and the anti-hyperuricemic activity in rats. The formulations exhibited nanometric size, a narrow size distribution, and a negative zeta potential, indicating their stability and uniformity. The efficient encapsulation of the sesquiterpene lactones within the liposomes emphasizes their potential for sustained release and therapeutic efficacy. Stability evaluation revealed a small decrease in the eremantholide C concentration and a remarkable stability in the goyazensolide concentration. In Caco-2 cells, the liposomes did not exert toxicity, but did exhibit an antiproliferative effect. In vivo assays demonstrated that the liposomes reduced serum uric acid levels. Our study represents an advancement in gout and hyperuricemia treatment. The liposomal formulations effectively reduced the toxicity associated with the sesquiterpene lactones while maintaining their therapeutic effects.<\/jats:p>","DOI":"10.1038\/s41598-024-57663-1","type":"journal-article","created":{"date-parts":[[2024,3,24]],"date-time":"2024-03-24T12:01:26Z","timestamp":1711281686000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Development and characterization of liposomal formulations containing sesquiterpene lactones for the treatment of chronic gout"],"prefix":"10.1038","volume":"14","author":[{"given":"Rafaela","family":"Cunha Matosinhos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Fr\u00e9zard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Mendes Silva Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andressa","family":"Magalh\u00e3es Barbosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabela Fernanda","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Dias","family":"de Souza Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Paula","family":"Corr\u00eaa Oliveira Bahia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Ietta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnese","family":"Magnani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00eania Antunes","family":"Sa\u00fade-Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,24]]},"reference":[{"key":"57663_CR1","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1002\/art.41247","volume":"72","author":"JD FitzGerald","year":"2020","unstructured":"FitzGerald, J. D. et al. American College of Rheumatology guideline for the management of gout. Arthritis Rheumatol. 72, 879\u2013895 (2020).","journal-title":"Arthritis Rheumatol."},{"key":"57663_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12944-020-1197-y","volume":"19","author":"J Liang","year":"2020","unstructured":"Liang, J. et al. The comparison of dyslipidemia and serum uric acid in patients with gout and asymptomatic hyperuricemia: A cross-sectional study. Lipids Health Dis. 19, 31 (2020).","journal-title":"Lipids Health Dis."},{"key":"57663_CR3","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.rbr.2016.03.006","volume":"57","author":"EA Fernandes","year":"2017","unstructured":"Fernandes, E. A. et al. Aspectos relevantes do diagn\u00f3stico e seguimento por imagem na gota. Rev. Bras. Reumatol. 57, 64\u201372 (2017).","journal-title":"Rev. Bras. Reumatol."},{"key":"57663_CR4","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1056\/NEJMoa035700","volume":"350","author":"HK Choi","year":"2004","unstructured":"Choi, H. K., Atkinson, K., Karlson, E. W., Willett, W. & Curhan, G. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N. Engl. J. Med. 350, 1093\u20131103 (2004).","journal-title":"N. Engl. J. Med."},{"key":"57663_CR5","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.berh.2010.10.004","volume":"24","author":"EUR Smith","year":"2010","unstructured":"Smith, E. U. R., D\u00edaz-Torn\u00e9, C., Perez-Ruiz, F. & March, L. M. Epidemiology of gout: An update. Best Pract. Res. Clin. Rheumatol. 24, 811\u2013827 (2010).","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"57663_CR6","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1136\/ard.2006.055269","volume":"65","author":"W Zhang","year":"2006","unstructured":"Zhang, W. et al. EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for international clinical studies including therapeutics (ESCISIT). Ann. Rheum. Dis. 65, 1312\u20131324 (2006).","journal-title":"Ann. Rheum. Dis."},{"key":"57663_CR7","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1093\/rheumatology\/kem056a","volume":"46","author":"KM Jordan","year":"2007","unstructured":"Jordan, K. M. et al. British Society for Rheumatology and British health professionals in rheumatology guideline for the management of gout. Rheumatology 46, 1372\u20131374 (2007).","journal-title":"Rheumatology"},{"key":"57663_CR8","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jbspin.2020.05.002","volume":"87","author":"T Pascart","year":"2020","unstructured":"Pascart, T. et al. 2020 recommendations from the French Society of Rheumatology for the management of gout: Urate-lowering therapy. Jt. Bone Spine 87, 395\u2013404 (2020).","journal-title":"Jt. Bone Spine"},{"key":"57663_CR9","first-page":"51","volume":"15","author":"HS Hassan","year":"2023","unstructured":"Hassan, H. S., Al-Osami, M. J., Al-Hakeimand, H. K. & Rufaie, M. M. M. Gout: A reviewing of the recent literature. Egypt. Acad. J. Biol. Sci. 15, 51\u201358 (2023).","journal-title":"Egypt. Acad. J. Biol. Sci."},{"key":"57663_CR10","first-page":"80","volume":"10","author":"T Riaz","year":"2023","unstructured":"Riaz, T. et al. A review of medicinal plants for the treatment of Gout. IAIM 10, 80\u201387 (2023).","journal-title":"IAIM"},{"key":"57663_CR11","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1080\/14728222.2023.2247559","volume":"27","author":"TH Zaninelli","year":"2023","unstructured":"Zaninelli, T. H. et al. New drug targets for the treatment of gout arthritis: What\u2019s new?. Expert Opin. Ther. Targets 27, 679\u2013703 (2023).","journal-title":"Expert Opin. Ther. Targets"},{"key":"57663_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.tifs.2022.03.002","volume":"123","author":"S Feng","year":"2022","unstructured":"Feng, S., Wu, S., Xie, F., Yang, C. S. & Shao, P. Natural compounds lower uric acid levels and hyperuricemia: Molecular mechanisms and prospective. Trends Food Sci. Technol. 123, 87\u2013102 (2022).","journal-title":"Trends Food Sci. Technol."},{"key":"57663_CR13","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.tifs.2023.06.021","volume":"138","author":"J Wu","year":"2023","unstructured":"Wu, J., Alhamoud, Y., Lv, S., Feng, F. & Wang, J. Beneficial properties and mechanisms of natural phytochemicals to combat and prevent hyperuricemia and gout. Trends Food Sci. Technol. 138, 355\u2013369 (2023).","journal-title":"Trends Food Sci. Technol."},{"key":"57663_CR14","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.bjp.2018.12.008","volume":"29","author":"ACFPF Bernardes","year":"2019","unstructured":"Bernardes, A. C. F. P. F., Coelho, G. B., Ara\u00fajo, M. C. P. M. & Sa\u00fade-Guimar\u00e3es, D. A. In vivo anti-hyperuricemic activity of sesquiterpene lactones from Lychnophora species. Rev. Bras. Farmacogn. 29, 241\u2013245 (2019).","journal-title":"Rev. Bras. Farmacogn."},{"key":"57663_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2020.113738","volume":"269","author":"ACFPF Bernardes","year":"2021","unstructured":"Bernardes, A. C. F. P. F. et al. Sesquiterpene lactones from Lychnophora species: antinociceptive, anti-inflammatory, and antioxidant pathways to treat acute gout. J. Ethnopharmacol. 269, 113738 (2021).","journal-title":"J. Ethnopharmacol."},{"key":"57663_CR16","first-page":"1","volume":"4","author":"BM Marinho","year":"2023","unstructured":"Marinho, B. M., Lescano, C. H. & Santos, S. H. S. Brazilian arnicas: Bioactive compounds, pharmacological properties, potential use and clinical applications. Phytochem. Rev. 4, 1\u201336 (2023).","journal-title":"Phytochem. Rev."},{"key":"57663_CR17","doi-asserted-by":"publisher","first-page":"166","DOI":"10.2174\/1570163816666190101113434","volume":"17","author":"F Torrens","year":"2020","unstructured":"Torrens, F. & Castellano, G. Structure-activity relationships of cytotoxic lactones as inhibitors and mechanisms of action. Curr. Drug Discov. Technol. 17, 166\u2013182 (2020).","journal-title":"Curr. Drug Discov. Technol."},{"key":"57663_CR18","doi-asserted-by":"publisher","first-page":"991","DOI":"10.3390\/pharmaceutics13070991","volume":"13","author":"MS Matos","year":"2021","unstructured":"Matos, M. S., Anast\u00e1cio, J. D. & Santos, C. N. Sesquiterpene lactones: promising natural compounds to fight inflammation. Pharmaceutics 13, 991 (2021).","journal-title":"Pharmaceutics"},{"key":"57663_CR19","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1111\/jphp.12783","volume":"69","author":"TG Caldeira","year":"2017","unstructured":"Caldeira, T. G., Sa\u00fade-Guimar\u00e3es, D. A., Dezani, A. B., Serra, C. H. R. & De Souza, J. In silico and in vitro prediction of gastrointestinal absorption from potential drug eremantholide C. J. Pharm. Pharmacol. 69, 1468\u20131476 (2017).","journal-title":"J. Pharm. Pharmacol."},{"key":"57663_CR20","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1093\/jpp\/rgac020","volume":"74","author":"IDT Tana","year":"2022","unstructured":"Tana, I. D. T. et al. Biopharmaceutics studies applied to goyazensolide: a drug candidate from Lychnophora species. J. Pharm. Pharmacol. 74, 1140\u20131151 (2022).","journal-title":"J. Pharm. Pharmacol."},{"key":"57663_CR21","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1590\/S0100-879X1999000200006","volume":"32","author":"F Fr\u00e9zard","year":"1999","unstructured":"Fr\u00e9zard, F. Liposomes: From biophysics to the design of peptide vacines. Braz. J. Med. Biol. Res. 32, 181\u2013189 (1999).","journal-title":"Braz. J. Med. Biol. Res."},{"key":"57663_CR22","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1166\/jcsb.2012.1020","volume":"1","author":"A Laouini","year":"2012","unstructured":"Laouini, A. et al. Preparation, characterization and applications of liposomes: State of the art. J. Colloid Sci. Biotechnol. 1, 147\u2013168 (2012).","journal-title":"J. Colloid Sci. Biotechnol."},{"key":"57663_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2022.963004","volume":"10","author":"X Cheng","year":"2022","unstructured":"Cheng, X. et al. Liposomes as multifunctional nano-carriers for medicinal natural products. Front. Chem. 10, 963004 (2022).","journal-title":"Front. Chem."},{"key":"57663_CR24","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.2147\/DDDT.S355059","volume":"16","author":"T An","year":"2022","unstructured":"An, T., Yin, H., Lu, Y. & Liu, F. The emerging potential of parthenolide nanoformulations in tumor therapy. Drug Des. Dev. Ther. 16, 1255\u20131272 (2022).","journal-title":"Drug Des. Dev. Ther."},{"key":"57663_CR25","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.2147\/IJN.S106548","volume":"12","author":"MY Want","year":"2017","unstructured":"Want, M. Y. et al. Nanoliposomal artemisinin for the treatment of murine visceral leishmaniasis. Int. J. Nanomed. 12, 2189\u20132204 (2017).","journal-title":"Int. J. Nanomed."},{"key":"57663_CR26","unstructured":"Zuo, J. Erding Formula and Bioactive Markers in Hyperuricemia: Towards Rational Scientific Approaches for the Modernization of Traditional Chinese Medicine (2019)."},{"key":"57663_CR27","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1002\/mrc.2093","volume":"45","author":"DA Sa\u00fade-Guimar\u00e3es","year":"2007","unstructured":"Sa\u00fade-Guimar\u00e3es, D. A. et al. Complete assignments of 1H and 13C NMR data for trypanocidal eremantholide C oxide derivatives. Magn. Reson. Chem. 45, 1084\u20131087 (2007).","journal-title":"Magn. Reson. Chem."},{"key":"57663_CR28","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1590\/S1516-05722014000200017","volume":"16","author":"DA Sa\u00fade-Guimar\u00e3es","year":"2014","unstructured":"Sa\u00fade-Guimar\u00e3es, D. A., Raslan, D. S. & De Oliveira, A. B. In vitro antitumor activity of sesquiterpene lactones from Lychnophora trichocarpha. Rev. Bras. Plantas Med. 16, 275\u2013282 (2014).","journal-title":"Rev. Bras. Plantas Med."},{"key":"57663_CR29","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.jep.2017.01.017","volume":"198","author":"BCA Ugoline","year":"2017","unstructured":"Ugoline, B. C. A. et al. The influence of seasonality on the content of goyazensolide and on anti-inflammatory and anti-hyperuricemic effects of the ethanolic extract of Lychnophora passerina (Brazilian arnica). J. Ethnopharmacol. 198, 444\u2013450 (2017).","journal-title":"J. Ethnopharmacol."},{"key":"57663_CR30","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1590\/S0100-40422012001100020","volume":"35","author":"ACF Soares","year":"2012","unstructured":"Soares, A. C. F., Silva, A. N., Matos, P. M., Da Silva, E. H. & Heleno, V. C. G. Complete 1H and 13C NMR structural assignments for a group of four goyazensolide-type furanoheliangolides. Qu\u00edm. Nova 35, 2205\u20132209 (2012).","journal-title":"Qu\u00edm. Nova"},{"key":"57663_CR31","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/0005-2736(73)90408-2","volume":"298","author":"S Batzri","year":"1973","unstructured":"Batzri, S. & Korn, E. D. Single bilayer liposomes prepared without sonication. Biochim. Biophys. Acta 298, 1015\u20131019 (1973).","journal-title":"Biochim. Biophys. Acta"},{"key":"57663_CR32","unstructured":"Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria. Guia de Estabilidade de Produtos Cosm\u00e9ticos\/Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria. 1st ed. (2004)."},{"key":"57663_CR33","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/0005-2736(80)90118-2","volume":"597","author":"TM Allen","year":"1980","unstructured":"Allen, T. M. & Cleland, L. G. Serum-induced leakage of liposome contents. BBA 597, 418\u2013426 (1980).","journal-title":"BBA"},{"key":"57663_CR34","unstructured":"United States Pharmacopeia. 37th ed. (United States Pharmacopeial Convention, 2014)."},{"key":"57663_CR35","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.1984","volume":"6","author":"EA Orellana","year":"2016","unstructured":"Orellana, E. A. & Kasinski, A. L. Sulforhodamine B (SRB) assay in cell culture to investigate cell proliferation. Bio-protocol 6, e1984 (2016).","journal-title":"Bio-protocol"},{"key":"57663_CR36","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jep.2009.04.026","volume":"124","author":"V Murugaiyah","year":"2009","unstructured":"Murugaiyah, V. & Chan, K. L. Mechanisms of antihyperuricemic effect of Phyllanthus niruri and its lignan constituents. J. Ethnopharmacol. 124, 233\u2013239 (2009).","journal-title":"J. Ethnopharmacol."},{"key":"57663_CR37","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jep.2016.01.007","volume":"180","author":"FC Ferrari","year":"2016","unstructured":"Ferrari, F. C. et al. Effects of Pimenta pseudocaryophyllus extracts on gout: anti-inflammatory activity and anti-hyperuricemic effect through xantine oxidase and uricosuric action. J. Ethnopharmacol. 180, 37\u201342 (2016).","journal-title":"J. Ethnopharmacol."},{"key":"57663_CR38","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/0024-3205(90)90507-N","volume":"46","author":"IH Hall","year":"1990","unstructured":"Hall, I. H., Scoville, J. P., Reynolds, D. J., Simlot, R. & Duncan, P. Substituted cyclic imides as potential anti-gout agents. Life Sci. 46, 1923\u20131927 (1990).","journal-title":"Life Sci."},{"key":"57663_CR39","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry, O. H., Rosebrough, N. J., Farr, A. L. & Randall, R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265\u2013275 (1951).","journal-title":"J. Biol. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-57663-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-57663-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-57663-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,24]],"date-time":"2024-03-24T12:01:51Z","timestamp":1711281711000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-57663-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,24]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["57663"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-57663-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,24]]},"assertion":[{"value":"30 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6991"}}